Drugs / VBY-891
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT01947738 | Mar → May 2013 | — | Virobay Inc. | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VBY-891 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01947738 ↗ |
| Action | Inhibit | “Cathepsin S inhibitor” NCT01947738 ↗ |
| Route | Oral | “Oral doses of VBY-891” NCT01947738 ↗ |